News  on CML - Archives 2017-2015)  ​

                                                                                                                                See our disclaimer

                  See News on CML (after 2020)
                  See Archives ( 2017-2016)
                  See Archives ( 2015-2014)
                  See Archives ( 2013-2012)
                                 See Archives ( 2011 and before)

​​

Omitting cytogenetic assessment from routine treatment response monitoring in CML is safe
December 29, 2017, European Journal of Haematology

MolecularMD Gets FDA Authorization for Companion Dx to Novartis CML Drug
December 27, 2017, GenomeWeb

Nilotinib Label for CML Updated by FDA With Discontinuation Provision
December 26, 2017, Targeted  Oncology

Managing TKI Therapy in CML
December 22, 2017,  Targeted  Oncology

The Deciding Factors for CML Treatment
December 22, 2018,  Targeted  Oncology

MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna
December 22, 2017, Markets Insider
 
Radioactive Iodine Increases Risk of AML, CML in Patients With Thyroid Cancer
December 19, 2017, Cancer therapy advisor

FDA Approves Bosutinib for Newly-Diagnosed Ph+ CML
December 19, 2017,  OncLive

Jorge Cortes, MD, shares data presented at ASH 2017 regarding bosutinib in CML treatment  VIDEO
December 18, 2017, OBRoncology

What is treatment free remission in chronic myeloid leukemia?
December 18, 2017, PubMed

Auto-Commentary on: “Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells”
December 17, 2017, Molecular & Cellular Oncology

Peripheral Artery Occlusive Disease Among Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Case-Control Study
December 15, 2017, PublMed

Older adults underrepresented in clinical trials for blood cancers
December 15, 2017, Healio

Arterial Thrombotic Events Associated With First-line Nilotinib for CML in Older Adults
December 11, 2017, Oncology Nurse Advisor
 
Nilotinib Dose, Frequency Reduction Maintains Efficacy in Chronic Myeloid Leukemia
December 10, 2017, Cancer Therapy Advisor

Sprycel (dasatinib) Added to Standard Chemotherapy Demonstrates Three-Year Survival Benefit in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
December 9, 2017, Business Wire

Treatment-free remission in CML: who, how, and why?
December 8, 2017, PubMed

Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells
December 7, 2017, NCBI

​​Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
December 7, 2017, Select Science

C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro
December 7, 2017, Nature

​More Communication, Support Needed to Manage Symptom Burden in CML    
December 6, 2017, Oncology Nurse Advisor

Systematic Review Finds Elevated Reporting for Thromboembolic Events With JAK Inhibitors
December 05, 2017, AJMC

Inotuzumab Ozogamicin Plus Bosutinib May Be Safe, Effective for Relapsed/Refractory ALL and CML  
November 30, 2017, Cancer Therapy Advisor
​
Imatinib Effective as Front-line Therapy for Pediatric Chronic Myeloid Leukemia
November 30, 2017, Cancer Therapy Advisor

I’m A Doctor With Chronic Illness. Here Are 12 Things I Wish People Knew
November 28, 2017, Huffingonpost

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
November 28, 2017, PublMed

Do Additional Chromosomal Abnormalities Noted at CML Diagnosis Affect Response and Survival?             
November 16, 2017, Cancer Therapy Advisor

​Immature CML cells implement a BMP autocrine loop to escape TKI treatment
November 14, 2017, Journal Blood

FDA Approves Dasatinib for Pediatric Ph+ Chronic Phase CML
November 10, 2017, OncLive
​
​Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
November 9, 2017, American Journal of Hematology

Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation
November 9, 2017, PublMed

Brian Boyle scores emotional first goal since cancer diagnosis (Video)
November 9, 2017, NBC sports
​
Treatment-free remission in chronic myeloid leukaemia  VIDEO
November 2, 2017, cmladvocates

​​Bosutinib May Be Superior to Imatinib for Newly Diagnosed CML
November 1, 2017, Cancer Therapy Advisor

​Vitamin C Treatment Restores TET2 Deficiency and Confers Sensitivity to PARP Inhibition
October 27, 2017, The hematologist

Bosutinib Safe, Effective in Second and Third Line Among Patients With CML
October 27, 2017. Cancer Therapy Advisor

Artist creates mural to honor Boyle's fight against CML
October 23, 2017, NHL news

Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting
October 2017, PublMed

Gaps Found in Monitoring of Response to TKI Therapy in CML
October 4, 2017, Cancer Network
 
Celyad reports a first complete response in a relapsed refractory AML patient in the THINK trial
October 3, 2017, Celyad

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series
October 2, 2017, PubMed

The Role of Mutation Testing in Patients with Chronic Myeloid Leukemia in Chronic Phase after Imatinib Failure and Their Outcomes after Treatment Modification: Single-institutional Experience Over 13 Years
September 2017, Indian J Med Paediatr Oncol. 

What's on the Horizon for Chronic Myeloid Leukemia?
September 27, 2017, LLS  

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows
September 26, 2017, News Medical
 
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
September 23, 2017, Science Business
 
A network of hope and strength: Living with CML
September 23, 2017, The Daily Star
 
Leukemia Patients Celebrate 10th World CML Day
September 22, 2017, This Day

Phase III clinical trial (RERISE study) results of Efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia
September 22, 2017, PublMed

Trial Compares Bosutinib and Imatinib for First-Line CML Rx
September 21, 2017, Clinical Oncology News
 
The Importance of Spotting Leukemia
September 20, 2017, News-Medical.net

Jason Blake, who continued career after leukemia diagnosis, knows what Brian Boyle is facing
September 20, 2017, The Hockey news

Imatinib a Double-Edged Sword for Patients With CML Who Become Pregnant
September 19, 2017, Medscape
 
Targeted antibiotic use may help cure chronic myeloid leukaemia
September 19, 2017, Medical Xpress
 
Devils' Brian Boyle diagnosed with leukemia
September 19, 2017, USA Today

The Transformation of CML Treatment and Care       VIDEO
September 15, 2017, Patient Power

Bosutinib Distinguishes Itself as Potential Option for Newly-Diagnosed CML
September 15, 2017, Targeted Oncology
 
US Clears First & Latest “Living Drug” for Leukemia Cancer Treatment
September 13, 2017, Chronic Diseases
 
Hearing impairment helps him portray character
September 12, 2017, Chron

Dr. Jorge Cortes Joins Dr. Andre Goy and Dr. Sagar Lonial as Co-Chair for the Landmark Physicians’ Education Resource® International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
September 06, 2017,  Business Wire

Using Patient Variables in CML to Guide Treatment
September 5, 2017, Cancer Network
 
Experiences with cancer drive mother, daughter to complete triathlon
September 4, 2017, Chicago Tribune

How I Treat In Brief: Atypical Chronic Myeloid Leukemia
September 1, 2017,  ASH Clinical News

Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
September 1, 2017, Leukemia
 
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
August 2017, ClinicalTrial.gov

Natural Killer-Cell Counts Are Associated With Molecular Relapse-Free Survival After Imatinib Discontinuation In Chronic Myeloid Leukemia: The IMMUNOSTIM Study
August 2017, Haemetalogica.org

The University of Glasgow is deeply saddened to learn of the passing of Professor Tessa Holyoake. 
August 31, 2017, University of Glasgow
 
Bosulif Granted Priority Review in CML
August 30, 2017, Curetoday.com
 
FDA and EMA Accept Regulatory Submissions for Chronic Myeloid Leukemia Treatment
August 29, 2017, Rare Disease Report
 
U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
August 29, 2017, Business wire
 
First-line imatinib at 10 years: CML patients achieve 'close to normal life expectancy'
August 29, 2017, medwireNews
​
Last Days? Ryan O’Neal’s Cancer May Have Returned, Friends Fear
Aug 25, 2017, Radar Online

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia
August 23, 2017,  Publmed

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
August 4, 2017, NCBI

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
August 2017, -  European Society for Medical Oncology

New Norton panther statue inspired by fallen football player
July 22, 2017, Akron Beacon Journal
 
CML Patients Approach Normal Life Expectancy With Imatinib Treatment
July 21, 2017, Cancer Network Hematology

FDA Grants Priority Review for New Leukemia Option
July 20, 2017, Cancer Network

Patients misled: Indian drugs of uncertain quality are replacing FDA approved products
July 17, 2017, AEI
 
New Approach to Leukemia Can Help Improve Successful Treatment
July 14, 2017, Drug Discovery & Development
 
Genetically enhanced, cord-blood derived immune cells strike B-cell cancers
July 13, 2017, Science Daily

DESTINY Study: De-Escalation of TKIs Is Safe for Patients With CML
July 13, 2017, ASH Clinical News
 
FDA will review bid to extend label for Sprycel in chronic myeloid leukemia
July 12, 2017, The Pharma Letter
 
Novel approach to leukemia therapy can safely improve treatment success, reduce side effects
July 12, 2017,
 
Sprycel Granted Priority Review for Pediatric CML
July 11, 2017,   Curetoday

Survival in Imatinib-Treated CML Independent of Response Time
July 10, 2017, Medscape
 
PROFESSOR TESSA HOLYOAKE PRESENTED WITH ROYAL MEDAL BY THE QUEEN
July 7, 2017, University of Glasgow
 
Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase
July 6, 2017, PublMed
 
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia
July 4, 2017, PublMed

Pfizer assembles findings from 13 cancers for American Society of Clinical Oncology
July 2, 2017, Patient Daily
 
Dasatinib in Children: An Effective Alternative to Imatinib
June 29, 2017, Medscape
 
Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature
June 27, 2017, Dove Medical Press
 
TKI Discontinuation for Patients With CML Could Save Billions
June 26, 2017, Cancer Therapy Advisor
 
Kareem Abdul-Jabbar to keynote Dayton cancer symposium
June 26, 2017, Dayton Daily News

Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy
June 24, 2017, PublMed

Novartis data shows half of eligible Ph+ CML-CP patients remain in Treatment-free Remission nearly two years after stopping Tasigna®
June 23,2017,  GlobeNeswwire
 
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations
June 23,2017, P&T Community
 
Frontline bosutinib 'an option' for newly diagnosed CP CML
June 22, 2017, medwireNews

Relay for Life set June 23; Long chosen as Honorary Survivor
June 15, 2017, State Gazette
 
Bristol-Myers Squibb says Phase II of Sprycel in pediatric chronic myeloid leukemia cases shows promise
June 10, 2017, Patient Daily
 
Despite a rare cancer diagnosis and $12000-a-month medication, this couple is staying positive
June 9, 2017, Duluth News Tribune

 Bosutinib vs Imatinib for First-line Chronic Myeloid Leukemia Treatment
June 7, 2017, Cancer Therapy Advisor
 
Study: Pharma Payments Correlate To Higher Prescription Rates              
June 7, 2017, WUNC
 
Novartis drug Tasigna receives EU approval 
June 6, 2017, The FINANCIAL
 
Frontline Bostunib vs Imatinib in Chronic Myeloid Leukemia
June 6, 2017, Cancer Network

Comparing Bosutinib Versus Imatinib in Newly Diagnosed CML   VIDEO
June 5, 2017, Targeted Oncology

Drug Helps Some Kids With Rare Type of Leukemia
June 5, 2017, WebMD
 
Repost: Celebrating Brian Druker (ASCO 2017) and Basic Research
June 5, 2017, PLoS Blogs
 
Remembering Dr. Steve Collins
June 2, 2017,  Fred Hutch

Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias
June 2017, Clinical  Lymphoma, Myeloma and leukemia

​​Dominic Sanders: 5 Fast Facts You Need to Know
May 27, 2017, Heavy
 
H. Jean Khoury, 50, hematologist and pioneer in leukemia research, dies
May 26, 2017, The Cancer Letter Publications
 
No silver bullet, but precision oncology can help doctors hit the target
May 23, 2017, The Pharma Letter
 
A remembrance of H. Jean Khoury, MD
May 22, 2017, Emory
 
Third-line TKI Increases Non-relapse Mortality After Allo-HSCT in CML
May 22, 2017, Cancer Therapy Advisor

European Medicines Agency Validates Application for Bristol-Myers Squibb’s Sprycel (dasatinib) in Children with Chronic Myelogenous Leukemia
May 19, 2017, BusinessWire
 
Could This Cancer Drug Benefit Patients with Severe Asthma?
May 19, 2017, Pharmacy Times
 
Metabolism harnessed to reverse aggressiveness in leukemia
May 17, 2017, Science Daily
 
Relay for Life Cart n' for a Cure a huge success
May 17, 2017, Westmoreland News
 
Single cell focus reveals hidden cancer cells
‎May 16, 2017‎, Medical Xpress
 
Airman beats leukemia into remission
May 13, 2017, Air Force Link
 
Research: Blood cancer is most prevalent at 42
May 13, 2017, The Standard

Cancer Experts, Patients, and Families Meet for Local Blood Cancer Conference
May 11, 2017, PR Web

Return to glory days? Decatur tops Battle Ground, secures 4A state berth
May 11, 2017, The News Tribune

Insurance Status Influences Chronic Myeloid Leukemia Survival Outcomes
May 9, 2017, Cancer Network

Push continues for Nova Scotia to cover cancer medications taken at home
May 8, 2017, Yarmouth county Vanguard

Novartis Has the Right Prescription for Profits
May 6, 2017, Barrons’s

BCR-ABL1 Transcript Type Predicts Outcomes After Imatinib in CML
May 4, 2017, Cancer Therapy Advisor
 
Bone marrow transplant next step in Barbosa's battle with Leukemia
May 4, 2017,  Federal Way Mirror
 
Hinsdale police investigating mother's death as a homicide         (She have CML since 2004)
May 4, 2017, WGNtv

Andover man lucky to be alive
May 2, 2017, Wellsville Daily Reporter

Challenges in Molecular Monitoring for CML Treatment Response
May 2, 2017, Cancer Network

CML patients in England win access to Incyte's Iclusig
May 2, 2017, PharmaTimes
 
These leukemia patients weren't supposed to survive. Here's how they defied the odds.
April 29, 2017, The Boston Globe

Two drugs from Massachusetts biotechs win FDA approval
April 28, 2017, The Boston Globe

'Long-awaited' NICE nod for Iclusig in England
April 28, 2017, The Pharma Letter

Characterizing Therapy-persistent Leukemic Stem Cells in CML
April 28, 2017, Cancer Therapy Advisor
 
Scientists create leukaemia online tool to aid global search for cure
April 27 2017, Medical Xpress

Novartis to pay $50M, lose some drug coverage in Korean bribery probe
April 27, 2017, FiercePharma

Rgenix hires ex-Novartis cancer staffer to trial GSK castoff
April 27, 2017, FierceBiotech

Sellas Testing Galinpepimut-S Vaccine as Potential Therapy in Blood and Solid Cancers
April 27, 2017, Immuno-Oncology News
 
The thin line between CML and CMML
April 27, 2017, Blood

Leukemia and Risk of Venous Thromboembolism: A Meta-analysis and Systematic Review of 144 Studies Comprising 162,126 Patients
April 26, 2017, Scientific Reports

Patients Have Mixed Responses Regarding Discontinuing TKI Therapy for Chronic Myeloid Leukemia
April 26, 2019, Oncology Nurse Advisor

The survivors: How an experimental treatment saved patients and changed medicine
April 25, 2017,  STAT

Lower dose may be feasible in older people
April 20, 2017, CML-IQ

Jaipur hospital launches project to help adults with cancer
April 20, 2017, The Hindu,

First-line generic imatinib offers 'suboptimal efficacy'
April 19, 2017, medwireNews

Atypical Chronic Myeloid Leukemia: Current Research and Treatment Strategies
April 17, 2017, Cancer Therapy Advisor

Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment
April 13, 2017, PublMed

Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia
April 12, 2017, PublMed

Transplant for Chronic Myeloid Leukemia          VIDEO
April 10, 2017, OncLive

Targeted cancer treatment; what's causing all these outbreaks of strange diseases?
April 7, 2017, Hometownfocus

Double trouble for CML - ABL001 and TKIs
April 5, 2017, Science Translational Medicine

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
April 4, 2017, NCBI

Relapse After CML Treatment Discontinuation
April 3, 2017, OncLive

Nilotinib Associated With Treatment-induced T2DM and Hyperlipidemia
March 31, 2017, Cancer Therapy Advisor

Chronic Myeloid Leukemia NEJM publishes long-term results of Gleevec for 1106 patients worldwide
March 30, 2017, The Cancer letter

Drastic cuts to NIH budget could translate to less innovation and fewer patents, study argues
March 30, 2017, Los Angeles Times

TKIs Associated With Subclinical Pulmonary Hypertension in CML Patients
March 29, 2017, Cancer Network

Corrigan will direct community band Sunday
March 29, 2017, Sierre Star
 
Novel Therapeutic Target Shows Promise in Treatment-Resistant Leukemia
March 29, 2017, Specialty Pharmacy Times

The chronic myeloid leukemia stem cell: stemming the tide of persistence
March 2017, Journal Blood

CML treatment-free remission possible with nilotinib
March 29, 2017, medwireNews

CML progression, outcome linked to smoking
March 29, 2017, medwireNews

Is Gleevec a Wonder Drug for Cancer Treatment?
March 28, 2017, Healthline News

How Big Data is Being Mobilized in the Fight Against Leukemia
March 27, 2017, dddmag

TKIs Linked to Pulmonary Hypertension in CML
March 27,2017,Cancer Therapy Advisor

Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib
March 27, 2017, PublMed

New vitamin may help DNA repair, reverse ageing process: Study
March 25, 2017, Business Standard

Immune Effector Recovery in Chronic Myeloid Leukemia and Treatment-Free Remission
April 24, 2017, NCBI

An Unexpected New Lung Function Has Been Found - They Make Blood
March 24, 2017, Science Alert

Striving to vanquish leukemia
March 22, 2017, Novartis

TKI Use in Medicare Beneficiaries With Chronic Myeloid Leukemia
March 22, 2017, Oncology Nursing News  

Pediatric Chronic Myeloid Leukemia: Targeting Treatment
March 22, 2017, Cancer Therapy Advisor

Parthenolide and DMAPT Induce Cell Death in Chronic Myeloid Leukemia Cells Via Generation of Reactive Oxygen Species
2016, journal Blood

Scientists find possible Achilles heel of treatment-resistant cancers
March 20, 2017, EnrekAlert

Chronic Myeloid Leukemia: How Big Data Is Helping In The Fight
March 19, 2017, ReliaWire

Imatinib efficacy for CML sustained over time
March 17, 2017,  medwireNews

Researchers find patients' annual financial burden under Medicare Part D is 'too much too soon'
March 17, 2017, Medical Xpress

Improvement Needed in CML BCR-ABL1 Monitoring
March 16, 2017, Cancer Therapy Advisor

Long-Term Response With Imatinib
March 14, 2017, Oncology Nursing News

SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis
March 14, 2017, Dove Medical Press

Full Transcript of Interview with Sellas on Galinpepimut-S Vaccine Being Tested for MPM
March 14, 2017, Mesothelioma Research News 

Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries
March 13, 2017, Journal of Cancer Research and Clinical Oncology

Strategies for Stopping TKIs in CML Growing Clearer
March 13, 2017, Clinical Oncology News

Novartis' leukemia treatment embroiled in efficacy
March 13, 2017, KBMBR

Treatment Choice in CML
March 13, 2017, OncLive 

Kite Pharma: History In The Making?
March 13, 2017, Seeking Alpha

The simple life: Nate
‎March 11, 2017‎, Keyser Mineral Daily News Tribune

Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
2017, Journal Blood

New made-in-Singapore cancer drug could lower leukaemia mortality
March 10, 2017, Channel NewsAsia

Made-in-Singapore drug for blood cancer to be tested
March 10, 2017,The Straits Times

A New Chapter Begins With CML
March 9, 2017, Cure

Cancer Pill Gleevec Keeps Patients Alive and Well for a Decade
March 9, 2017, NBC News

Chronic Myeloid Leukemia: Persistent Efficacy With Imatinib
March 9, 2017, Cancer Therapy Advisor

International Chronic Myeloid Leukemia Foundation honors Dr. Jerald Radich
March 9, 2017, Hutch News

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
March 9, 2017,  NEJM

Scientists Bet for Genetic 'Edition' of Cancer
March 8, 2017, Prensa Latina

Miracle drug with Israeli roots saves Jewish hockey player hit with cancer
March 8, 2017, Jewish Telegraphic Agency         
 
A New Chapter Begins With CML
March 8, 2017, Curetoday

Curing Chronic Myeloid Leukemia with Nilotinib or Dasatinib?
March 7, 2017, Journal Watch

Elbasvir/grazoprevir effective against HCV in those with blood disorders
March 6, 2017, Healio

Prof Tessa Holyoake recognised for ground-breaking research into CML
March 6, 2017, Glasgow, City of Science  and Innovation

Leukemia drug works so well that some patients are now quitting it
March 6, 2017, Pharmacy Today, American Pharmacists Association

Altoona mother, newborn son beat the medical odds
March 3, 2017, Pittsburgh Post-Gazette

Lin BioScience Licenses a Novel Anti-Cancer Therapy for Hematological Malignancies and Solid Tumors from Columbia University and Memorial Sloan Kettering Cancer Center - CDC7 inhibitor (LBS-007)
March 3, 2017, PRNewswire
 
Risk & reward: Stopping a cancer drug to see if you're cured
March 2, 2917, Huffpost

Sellas gives positive clinical update
March 2, 2017, BioPharma Dive

Risk & reward: Stopping a cancer drug to see if you're cured
March 2, 2017, abc news     (see the video)

No pain, no gain: the forgotten patient-reported outcome?
March 2017, The Lancet Haematology

CD86+ pDCs: A Marker for Treatment-free Remission in Chronic Myeloid Leukemia?
March 1, 2017, Cancer Therapy Advisor 

CML: Less Frequent Monitoring of BCR-ABL1 May Not Affect Outcomes
February 28, 2017, Cancer Therapy Advisor

Trump used a rare disease survivor to take a shot at the FDA
February 28, 2017, Vox

Man behind HelpSaveMatthew.com, Matthew Schreindorfer, dies after battle with cancer
February 27, 2017, Montreal Gazette

Second-Generation TKIs Can Be Stopped in Many CML Patients
February 26, 2017, Cancer Network

Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson's Disease
February 26, 2017, Newswise
 
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management
February 2017, Clinical Lymphoma Myeloma& Leukemia

Smoking Worsens Researchers identify factors associated with survival in patients with blast phase CML
February 24, 2017, Healio

Prognosis for Patients With CML
February 24, 2017, Cancer Network

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia
February 24, 2017, Leukemia
 
CML: First-line Generic Imatinib May Be Inferior to Branded Imatinib
February 23, 2017, Cancer Therapy Advisor

TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
February 18, 2017, NCBI

Cowboys, TeamConnor promoting marrow donor drive at The Star
February 16, 2017, Fort Worth Star

Stopping second-generation TKIs in CML
February 16, 2017, Journal Blood

Telegram   Assays Break New Ground in Oncology
February 15, 2017, OncLive

Your Good Health: Soldier's exposure to cannons reverberates in ears for years
February 15, 2017, Times Colonist

Smoking May Increase Risk of Death in Patients With CML
February 14, 2017, Cancer Therapy Advisor

Firefighters ask lawmakers to expand their health care coverage
February 12, 2017, Azfamily.com

New CML Data Post Signs on Route to Treatment-Free Remission
February 10, 2017, Medscape

Hybrigenics gives update on chronic myeloid leukemia study
February 10, 2017, pharmaceutical daily news

Advancing Leukemia Treatments from the Heart of Paris
February 10, 2017, Labiotech.eu
 
Frontline Bosutinib Superior to Imatinib for Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
February 9, 2017, OncolyNurseAdvisor

Neovia Starts Enrollment in Phase 1 Immunotherapy Trial for Advanced Cancers
February 9, 2017, Immuno-Oncology News

Chronic Myeloid Leukemia: CD86 Expression Predicts Relapse
February 7, 2017, Cancer Therapy Advisor  

Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience
February 6, 2017, World Journal of Hematology

Leukemia drug holds promise to treat type 2 diabetes
February 4, 2017, Knowridge Science Report

VIDEO: One Lowndes County Deputy Is Fighting More Than Just Crime
February 2, 2017, WCBI

Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug
February 1, 2017, Yahoo Finance

Immune reconstitution and remission in CML
2017, Blood

Book Review: Letters to Dr. Wiggy
January 31, 2017, The Pace Chronicle

New step therapy law called step in right direction
January 31, 2017, WBFO

Old Cancer Drug Gets 1227% Price Hike in Frugal U.K.
January 30, 2017, Bloomberg

New study into leukemia offers clearer understanding of its biology
January 27, 2017, Medical Xpress

Experience with Omacetaxine for TKI-Resistant TKI CML
January 26, 2017, OncLive

Seattle Biotech Neovia Begins Clinical Trial for Immunotherapy Enhancing Cancer Drug
January 25, 2017, PRNewswire

In CML, 'Half a Loaf' May Be as Good as None
January 25, 2017, MedPage Today

Two Infants Treated with Universal Immune Cells Have Their Cancer Vanish
January 25, 2017, MIT Technology Review

Single-cell epigenomic variability reveals functional cancer heterogeneity
January 24, 2017, Genome Biology

Newcastle researchers welcome CML leukaemia trial success/
January 24, 2017, BBC News

Former Penn professor and 1952 Penn Medicine grad who revolutionized cancer research has died
January 23, 2017, The Daily Pennsylvanian

Nilotinib for CML Associated With Improved Quality of Life à
January 23, 2017, Oncology Nurse Advisor  

Adding Pioglitazone to Imatinib May Improve Response in CML
January 23, 2017, Oncology Nurse Advisor

Alternative Mechanism for Treatment of Resistant CML
January 23, 2017, OncLive

CML stem cells: evasion for better invasion
2017, Journal Blood

Ponatinib: Black Box Warning and Drug Interactions
January 17, 2017,  Cancer Therapy Advisor

10 Questions: David Chang, MD, PhD
January 14, 2017, MedPage Today

Induction of p53 suppresses chronic myeloid leukemia
January 13, 2017, PublMed

Peter Nowell, who helped uncover first genetic sign of cancer, dies at 88
January 13, 2017, Press Herald

Peter Nowell, who has died at 88, revolutionized cancer research — by accident
January 12, 2017, Washington Post
 
Diagnosis and Upfront Therapy for CML    VIDEO
January 12, 2017, OncLive

TIDEL-II Trial for CML            VIDEO
January 12, 2017, OncLiveTV
 
Using next-generation sequencing to identify biomarkers in CML    VIDEO
January 10, 2017, VJHemOnc – Video Journal of Hematological Oncology

TKI Discontinuation and Chronic Myeloid Leukemia
January 10, 2017,  Cancer Therapy Advisor

Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial    VIDEO
January 10, 2017,   VJHemOnc 

Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib
January 8, 2017, PublMed

CD62L T-cell expression linked to TKI therapy response
January 6, 2017, medwireNews

Cancer death rate now 25% lower than 25 years ago, report says
Janvier 6, 2017, Chicago Tribune

Adding Pioglitazone Could Improve Molecular Response in CML Patients
Janvier 6, 2017, Cancer Network
  
Cancer deaths fell 25 percent since 1991
Janvier 6, 2017, WRCB-TV

Adding Pioglitazone to Imatinib May Improve Response Rate in CML
January  4, 2017,  Cancer Therapy Advisor

CML patients with deep molecular responses to TKI have restored immune effectors, decreased PD-1 and immune suppressors.
January 3, 2017, PublMed

Professor Peter C. Nowell, MD (1928-2016)
January 2, 2017, Pathology and Laboratory Medicine

Female and Elderly Chronic Myeloid Leukemia Patients Often Do Not Receive an Adequate TKI Treatment
Blood 2016, Journal Blood

Anti-Leukemic Effects of Venetoclax on Philadelphia Chromosome Positive Leukemia Cells
2016, Journal Blood

100 Years of Chronic Myeloid Leukemia Prevalence in France
December 2016, Journal Blood

Natural Killer Cells Play Role in Ability of CML Patients to Discontinue TKIs
December 29, 2016,  Cancer Network

Facing Cancer Diagnosis, Badass Young Woman Puts on Lipstick and Dances to "I'm a Survivor"
December 29, 2016, POPSUGAR

Give Precision Medicine a Chance
December 28, 2016, OncLive

Woman shares devastating cancer diagnosis with her family by creating hilarious video to show disease won't define her December 28, 2016, Mirror.co.uk

Combination Chemotherapy Shows Promise in Patients with Blood Cancers
December 28, 2016, Specialty Pharmacy Times

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study
December 27, 2016, Cancer

Faster, Better, Safer—Getting CML Treatment Right    VIDEO
December 23, 2016, PeerView Oncology

Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI.
December 23, 2016, PublMed

Family, community rally around Bessemer girl battling leukemia
December 16 2016,  New Castle News
                                                                               
Second Generation TKIs Can Be Safely Stopped in CML
December 13, 2016, Cancer Therapy Advisor

Safety Data for TKI Cessation Emerges for Chronic Myeloid Leukemia
December 6, 2016,  Curetoday.com

Pfizer, Avillion’s Bosulif comes out on top in first-line CML trial
December 6, 2016, PharmaTimes

CML Patients Receiving TKI Can Successfully Discontinue Tx
December 5, 2016, Medpage today

Cutting Dose, Instead of Stopping Therapy, in Patients With CML
December 5, 2016, Medscape

Leukemia Drug Bosulif Succeeds in Phase 3 Trial
December 5, 2016, Managed Care magazine
 
CML-CP: Second TKI Discontinuation Safe and Successful
December 5, 2016, Cancer Therapy Advisor

Halving the TKI dose safe, cost effective in CML patients with stable remissions
December 4, 2016, MDedge

At 2 Years, No CML Found in Half of Patients Who Stopped TKI Therapy
December 4, 2016, Cancer Network

TKI Cessation Strategies Emerging for CML
December 4, 2016, OncLive

Meeting the New Challenges in CML Therapy      VIDEO
December 2, 2016, iCMLf forum

Ponatinib Approved for CP-CML Not Indicated for Prior TKI
December 1, 2016,  Cancer Therapy Advisor
 
TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
November 30, 2016,  Cancer Therapy Advisor

Fecal Occult Blood Test With Colonoscopy May Detect Colitis Risk Among CML Patients
November 30, 2016,  Cancer Therapy Advisor
 
TKI-induced Cardiovascular Toxicity in Chronic Myeloid Leukemia
November 29, 2016, Cancer Therapy Advisor
 
FDA Fully Approves Iclusig for Chronic Myeloid Leukemia
November 29, 2016, Rare Disease Report
 
Summer Project Turns Into Leukemia Testing Breakthrough
November 28, 2016, New York Times

Pleural effusion linked to first-line dasatinib molecular response
November 28, 2016, medwireNews
 
CML somatic mutation analysis linked to patient outcome
November 28, 2016, medwireNews
 
Why Might Patients Skip Their Cancer Treatments, and How Can We Improve Compliance?
November 25, 2016, Curetoday.com
 
Bosutinib Offers Long-Term Efficacy in CML Patients Who Failed TKI Therapy
November 23, 2016, Cancer Network
 
Transforming cancer care in MENA region
November 23, 2016, Kuwait Times

The importance of mutational analysis in chronic myeloid leukemia
November 22, 2016, EMJ
 
Money in Medicine: Brian Druker on why he gets money from Gilead, not Gleevec
November 22, 2016, Portland Business Journal
 
Elle Halliwell's sheer terror over battling leukemia while pregnant
November 21, 2016, Yahoo7 Be

A little card with a big task: Saving lives from CML
November 18. 2016, Fred Hutch News Service
 
Over 75% of CDF drugs reappraised by NICE now approved for routine use
November 17, 2016, The pharmletter
 
Roche, Bristol-Myers cut cancer drug prices to win UK approval
November 16, 2016, Reuters
 
CRISPR gene-editing tested in a person for the first time
November 15, 2016, Nature
 
Darwinian Oncology Comes of Age: Evolutionary Biologists Offer Competing Theories of Cancer
November 14, 2016, Cancer Therapy Advisor

The Mast Cell: New Target in SpA?
November 12, 2016, Medpage Today

Bosutinib for CML After Progression With First-line TKI
November 10, 2016, Cancer Therapy Advisor  

CD62L Plasma Levels May Predict Response to TKIs in Early CML-CP
November 9, 2016, Cancer Therapy Advisor

Immune Cell Protein Expression Could Offer Predictive Biomarker in CML
November 9, 2016, Cancer Network

'One-fifth of cancer patients face work discrimination'
November 7, 2016, BBC News

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
November 7, 2016, Dove Medical Press

Generic imatinib for chronic myeloid leukaemia patients
November 4, 2016, Blood and Lymphatic cancer – Leukemia Care

Geron Announces Presentations at American Society of Hematology Annual Meeting
November 3, 2016, GlobeNewswire

CML Patients With Prior Malignancies Have Excellent Outcomes
October 28, 2016, Cancer Network

CML patient motivation for TFR remission attempts highlighted
October 28, 2016, medwireNews

MATE1 protein crucial for imatinib uptake
October 27, 2016, medwireNews

Model Suggests Best Option in CML Is Sequential Combination of Dasatinib and Nilotinib
October 25, 2016, Cancer Therapy Advisor

History of Prior Malignancies Do Not Appear to Affect CML Outcomes
October 24, 2016, Cancer Therapy Advisor

Why Cancer Patients Don't Take Their Medications
October 24, 2016, Medscape
 
Med School’s Hard Enough. This Guy's Doing It With Cancer – about Joshua Novy
October 20, 2016, Thrillist

Joshua Novy's Fundraiser: Cancer Patient helping other Cancer Patients
October 20, 2016, Crowdrise

Optimal treatment plan for chronic myeloid leukemia suggested by mathematical modeling
October 20, 2016, Medical Xpress

Childhood CML Survival Worst for Children Under 5 Years Old
October 19, 2016, Cancer Therapy Advisor

Long-term later-line bosutinib benefits CML patients
October 18, 2016, medwireNews

Targeted Power: Improving Prognoses for Patients With Chronic Myeloid Leukemia
October 17, 2016, Curetoday.com

Mutation Pattern Predicts Patients Likely To Fail TKI Therapy in CML
October 14, 2016, Cancer Therapy Advisor

Bernie Sanders' Tweet Cost This Drug Company Millions
October 14, 2016, Attn

Ariad raises price of its leukemia drug four times so far this year
October 13, 2016, American  Pharmacists Association
 
Disparities in Childhood CML Outcomes Persist Among Some European Countries and the US
October 11, 2016, Cancer Therapy Advisor
 
Lack of Cost-sharing Subsidies Reduces TKI Initiation and Adherence in CML
October 11, 2016, Cancer Therapy Advisor

Cancer in Retreat on One Front: Fewer Children Are Dying
October 10, 2016, The New York Times

Herbal Drug Proves Effective Against AML
October 10, 2016, Asian Scientist Magazine

Some Patients With Chronic Myelogenous Leukemia Delay Treatment Because of Cost
October 10, 2016, Curetoday.com
 
Dr. Jerald P. Radich on Treatment Considerations with Generic Imatinib in CML    VIDEO
October 8, 2016, OncLive

CML Patients on Medicare Delaying TKIs Due to Cost
October 6, 2016, Oncology Nursing News
 
Long-term Follow-up Confirms Safety of Imatinib Discontinuation in CML
October 5, 2016, Cancer Therapy Advisor

Cancer patients holding off on use of lifesaving medicine
October 5, 2016, News Chief

New drug delivery process gives hope to leukemia patients
October 3, 2016, The Times of India

Dr. Jerald Radich on Impact of Generic Imatinib in CML
October 1, 2016, OncLive

Incorporating Generic Imatinib Into Frontline Treatment for CML
October 1, 2016, OncLive

Prolonged Imatinib Therapy Linked With Deeper Molecular Response in CML-CP
September 27, 2016, Cancer Therapy Advisor

Combined Treatment May Lead to Cure for Chronic Myeloid Leukemia
September 26, 2016, Cancer Therapy Advisor
 
Leukemia patients stand strong
September 25, 2016, Daily Star

Imatinib Less Beneficial for Patients With CML in Accelerated Phase
September 23, 2016, Cancer Therapy Advisor

Response Rate Similar Between Low- and Standard-dose Ponatinib
September 23, 2016, Cancer Therapy Advisor

Compulsory License On Imatinib Mesylate – Drug Determined To Be Of Public Interest By The Colombian Government
September 21, 2016,  Mondaq News Alerts

Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
September 21, 2016 , Oncology Nurse Advisor

Citrus Valley football rallies behind Nelson Natividad in his battle with leukemia
September 20, 2016,  The Sun High School
 
EZH2 May Be Required for CML Initiation, Could Represent Therapeutic Target
September 19, 2016 , Cancer Network

Molecular monitoring in CML – getting  to a safe place   VIDEO
September 17, 2016, iCMLf

Precision medicine breakthrough for Chronic Myeloid Leukaemia
September 15, 2016,  University of Glasgow

Prospect of shorter treatment and cure for chronic myelogenous leukemia
September 14, 2016, Havard Gazette

High school cheerleader with cancer is moved to tears of joy after ALL 57 players on the football team place a rose at her feet at the start of a game
September 14, 2016, MailOnline

CML Patients Still Benefit from Transplant
September 13, 2016, MedPage Today
 
Leukaemia drug gets the green light for NHS use
September 13, 2016, Scottish Daily Record
 
Cancer Breakthrough: US Approves Leukemia Treatment
September 8, 2016, Diseases Cure

Combination therapy shows promise for chronic myeloid leukemia
September 7, 2016, Science Daily

Dr. Donnellan on TFR in Patients With CML Treated With Nilotinib      VIDEO
September 7, 2016, OncLive

Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
September 7, 2016,  Science translational Medicine

EUTOS Registry Represents Benchmark for Evaluation of New CML Treatments
September 6, 2016,  OncologyNurseAdvisor
 
This Type of Cancer is a Growing Concern in the Black Community
September 6, 2016,  The Milwaukee Community Journal
 
Chinese Cancer Patients Are Illicitly Importing and Preparing Their Own Drugs
September 1, 2016, Time             

Blood cancer treatment linked to distinct increase in molecular age of immune cells
September 1, 2016, News Medical
 
Higher EUTOS Risk Scores Linked With Delayed Response Rate in CML
August 31, 2016, Cancer Therapy Advisor

Dragway is benevolent
August 31, 2016, Clay Today Online

Living with blood cancer, leading a normal active life
August 30, 2016, The Straits Times
 
EUTOS Registry Shows Good CML Outcomes Outside Trials
August 30, 2016, Cancer network

I was diagnosed with Leukaemia & found out I was pregnant
August 30, 2016, Sporteluxe

Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer
August 26, 2016, Leukemia
 
Elle Halliwell finds out she is pregnant days after diagnosed with a rare cancer
August 26, 2016, Mail Online

Elle Halliwell reveals how she is coming to terms with having leukaemia and being pregnant with her first child      VIDEO
August 25, 2016, The Daily Telegraph

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
August 25, 2016, European Respiratory Journal

Be The Match and save a life
August 25, 2016, Index-Journal

NICE approves CDF drugs Alimta and Bosulif for routine NHS use
August 24, 2016, The Pharma Letter

Pfizer gobbles up cancer drug maker in $14 billion deal
August 24, 2016, World Socialist Web Site

Bacteria coaxed to deliver chemo drugs right inside tumours
ugust 17,  2016, CBCNews

Leukemia patient survey shows that serious issue patients should know
August 17, 2016, Daily Beast

These Ph.D. students are turning a cancer test into a business
August 16, 2016, Technically Baltimore

Nilotinib, Dasatinib Offer Similar Outcomes in CML Patients
August 15, 2016, Cancer Network

IBM's Watson Detected Rare Leukemia In Just 10 Minutes
August 15, 2016,  Asian Scientist Magazine

Dasatinib and Nilotinib Similarly Efficacious for CML in Chronic Phase
August 11, 2016, Cancer Therapy Advisor
 
 CML-CP: Dasatinib, Nilotinib Associated With Similar Survival Outcomes as Frontline Therapy
August 10, 2016, Oncology Nurse Advisor

Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia
August 10, 2016, Leukemia & Lymphoma

Phases of Chronic Myeloid Leukemia
August 9, 2016, News-Medical.net

ABCB1 Overexpression Predicts Poor Imatinib Response in CML Patients
August 9, 2016, Clinical Oncology News

ABCB1 mRNA Could Predict TKI Response in CML
August 5, 2016, Cancer Network
   
Young SOM Entrepreneurs Win National Contest
August 5, 2016,  UMB News

Cardiovascular events associated with use of TKIs in CML
August 5, 2016,  Pharmacy Today

Social Support Crucial for Patients With CML Receiving Lifelong Targeted Therapy
August 4, 2016, Oncology Nurse Advisor

Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients
July 29, 2016,  Journal of Hematology & Oncology

Fremont helps stranded Connecticut man
July 29, 2016, Fremont News Messenger

Early detection of leukemia patients' resistance to therapy
July 28, 2016, Science Daily

TKI Duration and Molecular Response Pivotal for Survival With Chronic Myeloid Leukemia
July 28, 2016, Cancer Therapy Advisor

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia
July 28, 2016, American Journal of Hematology

Half of Patients in Remission 11 Months After Nilotinib Discontinuation
July 28, 2016, Cancer Therapy Advisor

93 percent of advanced leukemia patients in remission after immunotherapy
April 27, 2016, ScienceDaily

Breakthrough brings blood cancer cure closer
July 27, 2016, The Advertiser

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia
July 28, 2016, American Journal of Hematology

Adelaide researchers in world-first breakthrough for people living with chronic myeloid leukaemia
July 27, 2016, Herald Sun

Line-up for Saturday Night with Miriam revealed
July 22, 2016, RTE
 
 Patients with Chronic Phase CML Can Safely Conclude TKI Treatment
July 21, 2016, Targeted Oncology
 
Veteran fights largest battle yet – cancer
July 14, 2016, Nassau County Record
 
Novartis cancer drug to be tested for Parkinson's disease
July 13, 2016,  FierceBiotech

Dubai-based Biologix FZCo. to distribute leukemia drug in the Middle East
July 13, 2016, Gulf News Journal

TKI-treated Patients With CML May Have Increased Risk of Vascular Events
July 13, 2016, Cancer Therapy Advisor

Ipilimumab Shows Impressive Activity After HSCT Failure
July 13, 2016, Medscape

Eastleigh Football Club raising funds for charity that saved manager Chris Todd's life
July 8, 2016, Southern Daily Echo

Oral chemo bill could save lives in Pa. — better late than never
July 6, 2016,  The Morning Call

Roz Purcell: 'We were advised to get a dog when my sister was diagnosed with cancer'
‎July 4, 2016‎, Irish Independent

Green Tea Helps Prevent And Treat Leukemia
July 4, 2016, Huffington Post Canada

Efficacy and safety of second-line ponatinib after failure of a single previous tyrosine kinase inhibitor for chronic myeloid leukemia patients in chronic phase
June 2016, Haematologica

Leukaemia drug shows promise in ovarian cancer (dasatinib)
June 30, 2016, PharmaTimes

Post-Transplant TKI Maintenance Yields Promising Results in High-Risk CML, ALL
June 29, 2016, Cancer Network

Life Span of CML Patients Approaches Usual Limits
June 28,2016, Medscape

Life Expectancy in CML Patients Approaching General Population's
June 24,2016, Cancer Network

Brexit big blow to UK science, say top British scientists
June 24, 2016, Theguardian

Brexit could lead to longer waiting times for new medicines, warn experts
June 23, 2016, Theguardian

New Findings on Chronic Myeloid Leukaemia, Possible Therapeutic Approaches
June 22,2016, Scicasts

Potential therapeutic approaches to combat chronic myeloid leukemia
June 21, 2016, News-Medical.net

CML No Longer Spells Early Death
June 20, 2016, MedPage Today

Babe Ruth’s granddaughter helps with local foundation
June 20, 2016, AJC.com

Choosing the most effective cure for chronic myeloid leukemia
June 17, 2016,TheSequitur.com

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia
June 17, 2016, Nature

Stopping TKI Treatment Is Safe for Patients With Chronic Myeloid Leukemia
June 16, 2016, Curetoday.com

ARIAD Launches CMLRisks.com To Expand Awareness Of Chronic Myeloid Leukemia Resistance And Intolerance
June 16, 2016, ClinicalLeader.com

Incidence of lymphocytosis linked to higher dasatinib response rate in CML
June 14, 2016, Healio

CML Remissions Continue Even After TKI Drugs Are Stopped
June 13, 2016, Medscape

Small-molecule tool could reduce leukemia cell regeneration
June 10, 2016, MedCity News

Stopping TKIs Proven Safe in Chronic Phase CML
June 10, 2016, OncLive
 
UC regents appoint Dr. Owen Witte University Professor
June 10, 2016, UCLA Newsroom

NICE Not Alone in Pushback on Cancer Drug Prices
June 10, 2016, AJMC.com Managed Markets Network

CML Patients Treated With TKIs May Have Increased Risk of Second Malignancies
June 10, 2016, Cancer Therapy Advisor
 
ARIAD Launches CMLRisks.com To Expand Awareness Of Chronic Myeloid Leukemia Resistance And Intolerance
June 10, 2016,  Clinical Leader
 
Chronic Myelogenic Leukemia Management in the TKI Era: Patient Compliance is Still Critical
June 9, 2016,  Cancer Therapy Advisor

Scientists identify drugs to target ‘Achilles heel’ of Chronic Myeloid Leukaemia cells
June 8, 2016, The University of Manchester

Cancer Breakthrough: Scientists find drugs to target ‘Achilles heel’ of leukaemia
Jun 8, 2016, Express

Cancer patients with ACA policies swiftly reach out-of-pocket caps
June 7, 2016 , Medical Xpress

Over 50% of eligible Ph+ CML patients maintain TFR after stopping Tasigna
June 5, 2016 , The Pharma Letter

Who Runs Washington? The Long Reach of Big-Pharma
June 4, 2016, Center for Research on Globalization

Nilotinib induces treatment-free remission in patients with chronic phase CML
June 4, 2016, Healio

New hope for chronic myelogenous leukemia patients: dasatinib offers better efficacy with shorter treatment
June 3, 2016, NCBI

The concept of treatment-free remission in chronic myeloid leukemia
June 3, 2016, Leukemia

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
June 3, 2016, Leukemia

Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna®
June 3, 2016, PRNewswire

My Husband's Rare Cancer
June 2, 2016, PLoS Blogs

Neither Trump nor Clinton a true leader
June 2, 2016, Kennebec Journal & Morning Sentinel

Scientists reveal breakthrough skin cancer drug
May 31, 2016, BABW News
 
Cancer survivor cycling to Paris for Bloodwise after Leukaemia diagnosis
May 28, 2016, Essex Chronicle
 
It's Blood Cancer Day, how is Biotech fixing it?
May 27, 2016, Labiotech.eu
 
11 Common Immune System Diseases and What They Do to You
May 26, 2016, Newsmax

Personalized Treatment for CML Through DNA Digital Assay
May 26, 2016, LWW Journals

NBA Legend's Message to Patients and Survivors of Cancer: Listen to Your Doctors
May 25, 2016, Curetoday.com

First-line Dasatinib Safe, Effective for Long-term Treatment of CML-CP
May 25, 2016, Cancer Therapy Advisor
 
DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 for the Treatment of Refractory Glioblastoma Multiforme
May 25, 2016, PRNewswire

Benzene suit filed against Texaco, 36 other companies for toxic emissions
May 24, 2016‎, Southeast Texas Record

Sunday Special: Jackson's Pritt sets sights on Olympic trials ‎
May 23, 2016‎, Canton Repository

Count-down to ASCO underway
May 23, 2016‎, The Pharma Letter

Generics help force drug prices lower
May 23, 2016,Sun Sentinel

Five-Year Results Support First-Line Dasatinib Use in CML
‎May 23, 2016‎, Cancer Network
 
Friends, relatives support cancer victims at Relay for Life
May 21, 2016, The Daily Item

BCR-ABL tyrosine kinase inhibitors: risk of hepatitis B reactivation
May 19, 2016, Gov.UK

30 years after cancer treatment, Encinitas man still rocking
May 19, 2016, Encinitas Advocate

ARIAD Announces Pricing and Reimbursement for Iclusig in France
May 19, 2016, Business Wire

Brexit would threaten world-class British research, major report warns
May 18, 2016,  Theguardian

Allogeneic HSCT offers good survival for select TKI-refractory CML patients
May 18, 2016, News Medical

CML treatment-free remission criteria outlined
May 18, 2016, News-Medical.net

How Colombia's Drugs Battle With Novartis Could Change Healthcare in Latin America
May 18, 2016, Americas Quaterly

Global Leukemia Therapeutic Market (2015 – 2021) : PMR
May 16, 2016, Medgadget.com

Health activist and surgeon Dr Gopal Dabade fights against corrupt medical practices
May 15, 2016,  Mid-day

Leaks Show Senate Aide Threatened Colombia Over Cheap Cancer Drug
May 14, 2016, The Intercept

Early recognition of intraventricular hemorrhage in the setting of thrombocytosis in the emergency department
‎May 12, 2016‎, Dove Medical Press
 
Cancer survivor graduates from UT Dallas
‎May 12, 2016‎, WFAA.com

‘Life-saver’ to be honored by Areyvut
May 11, 2016, New Jersey Jewish News

Cancer Drug Linked to Case of Scurvy
May 11, 2016, Monthly Prescribing Reference

Q&A With Dr. Elias Jabbour, MD, Highlights Evolving Treatment Landscape for CML, Pricing Barriers
May 11, 2016,  Cancer Therapy Advisor

13 Things To Remember If You Love Someone With Leukemia
May 10, 2016,  Diseases Cure

Barkle's sparkle in £5k charity challenge- inspired by brave Abi, 3, who is battling leukaemia
May 7, 2016, DorsetEcho

Prior Malignancies, Autoimmune Disorders Increased in CML Patients
May 5, 2016, Cancer Network

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation
May 5, 2016,  Onco target

Multitargeted Therapies Promiscuous Drugs and Combination Therapies Market: Historical, Current and Projected industry size and Recent Industry Trends
May 5, 2016,  medGadget
 
Mumbai Diary: Thursday Dossier
May 5, 2016, Mid-Day

Leukemia survivor deals with aftermath while in remission
May 5, 2016, manninglive

2 Sizzling Hot Biotechnology Stocks: Immunomedics Inc. (IMMU), CTI BioPharma Corp. (CTIC)
May 4, 2016, Zergwatch

Yissum and BioTheryX Sign Licensing Agreement for the Development of Next-Generation Protein Degradation and Immunomodulatory Treatment for Hematological Cancers
May 4, 2016,  PR Newswire

Colombia reportedly set to override Novartis patent on a key cancer drugColombia reportedly set to override Novartis patent on a key cancer drug
May 3, 2016, BioPharmaDive

PegIFN Improves Responses to Dasatinib in Newly Diagnosed CML Patients
‎May 3, 2016‎, Cancer Network
 
Argus-Courier wins four awards in CNPA Better Newspapers Contest
May 2, 2016‎, Argus Courier

Soon, centre to facilitate bone marrow transplantation in Indore ‎
May 1, 2016‎, Hindustan Times

Chronic myeloid leukemia: reminiscences and dreams
2016, Haematologica

A DNA Sequencer in Every Pocket
April 29, 2016, The Atlantic

Firefighters who donated bone marrow say it's an 'honor' to meet recipients whose lives they saved
April 29, 2016, New York Daily News

Art Therapy for Leukemia and Other Cancers
April 27, 2016, Sinthia Cousineau

Promising Secondary Endpoints for Ponatinib in CML Despite Early EPIC Trial Termination
April 26, 2016, Cancer Therapy Advisor

Pacritinib's Potential to Eradicate Therapy-Resistant Leukemia Stem Cells
April 25, 2016, LWW Journals  

Researchers Identify Risk Factors for Bosutinib-related Cardiac, Vascular Toxicities
April 25, 2016, Cancer Therapy Advisor  

Chronic inflammation leads to imbalanced blood system and potentially cancer risk
April 25, 2016, EurekAlert

How Ontario's stem-cell transplant waiting list failed a dying teen
Apr 23 2016, Toronto Metro

Vascular Events Remain Problem for Ponatinib in CML
Apr 22, 2016‎, Cancer Network
 
Bosutinib shows 'low' vascular, cardiac event risk profile
April 21, 2016‎, News-Medical.net

Targeted therapy: Generic imatinib — impact on frontline and salvage therapy for CML
‎Apr 21, 2016‎, Nature.com

Tailoring immune cells to target leukemia
April 21, 2016,  Fred Hutch
 
Bosutinib shows 'low' vascular, cardiac event risk profile
April 21, 2016, News-Medical.net
 
BCR-ABL halving time indicates CML prognosis during front-line TKI BCR-ABL halving time indicates CML prognosis during front-line TKI
April 21, 2016, News-Medical.net

Alpha-2, 3-sialyltransferases regulate the multidrug resistance of chronic myeloid leukemia through miR-4701-5p targeting ST3GAL1             
April 18, 2016, Nature.com

Cancer group coalition wins right to contest in Philippines poll
April 17, 2016 , Gulf News

Williams benefit Saturday at KCs
April 15, 2016, Jamestown Sun

CML molecular monitoring: Practical advice   VIDEO     
April 15, 2016, ImedexCME

Rapid BCR-ABL Reduction Is Predictive of Response in CML
April 15, 2016, Cancer Network

The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib
April 14, 2016, NCBI

Study compares ponatinib, imatinib for newly diagnosed chronic myeloid leukemia
April 14, 2016, Pharmacy Today

Efficacy of First-line Ponatinib in CP-CML Remains Unclear
April 14, 2016, Oncology Nurse Advisor
 
Ponatinib Currently Not Indicated As First Line CML Chronic Phase Therapy
April 13, 2016, MedicalResearch.com

Why can't Illinois patients grow their own weed?
April 13, 2016, Chicago Reader

Dickinson holds fourth annual bone marrow registry drive
April 13, 2016, The Sentinel
 
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
April 12, 2016, NCBI

Cost-sharing Creates Barrier to Treating Life-threatening Illness
April 12, 2016, Oncology Nurse Advisor

Closing Thoughts on Managing Chronic Myeloid Leukemia
April 11, 2016, OncLive 

A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
April 8, 2016, Blood Cancer Journal

A career in cancer research? Computational skills wanted
April 8, 2016, Science Mag

Value in health care: Time to stop scratching the surface
April 7, 2016, American Entreprise Institute

Generic imatinib cost-effective first-line treatment for CML
April 7, 2016, Healio

Relay for Life set for April 15 in Tifton
April 6, 2016, Tifton Gazette  

Medicare's catastrophic drug insurance can be a catastrophe for consumers
April 6, 2016, PBS NewsHour

Advice for Patients With CML Traveling While On Oral Chemotherapy
April 4, 2016,   OncologyNurseAdvisor

RAAF jet fuel: Submarine veterans call for recognition of 'link' between fuel and blood cancers
April 4, 2016,   ABC.net
 
Meet real Michiganders affected by state spending
April 4, 2016,   Lansing State Journal

Case Study: Selecting a Tyrosine Kinase Inhibitor in CML            VIDEO
April 1, 2016, OncLive

Stamp appeal grows in fight against cancer
April 1, 2016, Burton Mail   New Analysis Suggests 2013 ELN Categories Reliably

Predict CML Patient Long-term Outcomes
March 31, 2016, Cancer Therapy Advisor

Newer Generation TKIs May Be More Effective Than Imatinib for CP-CML
March 30, 2016 , Cancer Therapy Advisor

Oh, New Mutation? Now, We'll Try This Treatment
March 29, 2016, GenomeWeb

India's largest drug maker approved by US FDA Approval for Famous Anti Cancer – Corona Health
March 29, 2016, Daily Star Gazette

Scientists Find Accidental Cure for Type 2 Diabetes: Imatinib
March 29, 2016, AJMC.com Managed Markets Network

Dasatinib Commonly Induces Lymphocytosis in CML Patients
March 29, 2016, CancerNetwork

Increased Serum Creatinine Reversible Upon Imatinib Discontinuation
March 28, 2016, Cancer Therapy Advisor

Cancer Treatment's New Direction
March 28, 2016, Wall Street Journal

Ulsan National Institute of Science and Technology(UNIST)
March 27, 2016, EurekAlert
 
Dr. Brian Druker: "Anatomy of a Breakthrough in Targeted Cancer Treatments" | Talks at Google    VIDEO
March 25, 2016  Talks at Google

Patients With Additional Chromosomal Abnormalities in Chronic CML Have Worse Prognosis, Survival
March 23, 2016, Cancer Therapy Advisor

Delays in availability of affordable generic drugs exacerbate high cancer drug prices in the United States
March 23, 2016, Chron
 
EU High Court Upholds Orphan Exclusivity Ruling
March 23, 2016,  Regulatory Focus

Stem Cell Transplant in Chronic Myeloid Leukemia            VIDEO
March 22, 2016,  OncLive

Moving treatment-free remission into mainstream clinical practice in CML
March 22, 2016, Journal Blood

TGF-alpha, IL-6 Levels Predict Responses and Outcomes in CML
March 22, 2016,  Cancer Network
 
Generic Drug Could Slash Treatment Costs for Cancer Patients
March 21, 2016, MPR

The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia
March 21, 2016, Nature.com

Frontline Nilotinib Best Choice for Treatment of Patients With CML-CP
March 18, 2016, Cancer Therapy Advisor

Cancer Therapy Advisor   Kareem Abdul-Jabbar Discusses Living With CML         VIDEO
March 18, 2016, OncLive

Real-life data show feasibility of imatinib discontinuation in CML
March 17, 2016 News-Medical.net

Non-Hodgkin Lymphoma Elevated in Imatinib-Treated CML Survivors
March 16, 2016, Cancer Network  

Generic Gleevec Will Hurt Novartis -- But Save Millions In Health Costs
March 16, 2016, Forbes

Switching Therapy in Chronic Myeloid Leukemia                        VIDEO
March 15, 2016, OncLive

Using generic cancer drug could save many millions of dollars
March 15, 2016, Medical Xpress

DelMar's lead product candidate bags second Orphan Drug tag
March 15, 2016, Seeking Alpha

PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
March 14, 2016. Nature.com
 
Drug defies cancer and market logic
March 13, 2016, Concord Monitor

If you're 30+, you should know about this blood cancer
March 13, 2016,  Star2.com

Bucket list dreams come true for North Walsham schoolgirl with rare form of blood cancer
March 12, 2016,  Eastern Daily Press

Once Patent Protection Is Lost, Imatinib as Initial Treatment for CP-CML Will Be Most Cost-effective Strategy
March 11, 2016, Cancer Therapy Advisor
 
Dasatinib, Nilotinib Safe and Effective in CML Patients With Renal, Liver Dysfunction
March 11, 2016,  Cancer Network

Imatinib in 2016: What will the era of generic targeted therapy for cancer look like?
March 10, 2016, Healio
 
Leukemia claims Dartmouth Moosehead Dry pitcher at age
March 10, 2016, Cape Breton Post
 
This drug is defying a rare form of leukemia — and it keeps getting pricier
March 9, 2016, Washington Post

FDA Is Not the Problem
March 9, 2016, Center For American Progress
 
Could CypA facilitate cancer progression through the Abl-Crk signalling pathway?
March 9, 2016,  News-Medical.net

Managing Toxicities from CML Treatment
March 8, 2016, OncLive 

Estimating deep molecular responses in chronic myelogenous leukemia: a Bayesian approach
March 8, 2016, Leukemia
 
CML: How Previous TKIs Affect Outcomes with Ponatinib
March 8, 2016,  LWW Journals

Cost of foreign cancer drugs to be halved in Chinese public insurance pilot scheme
March 8, 2016,  South China Morning Post

Older Patients With CML at Higher Risk for Mortality, Vascular Events
March 8, 2016, Cancer Therapy Advisor

Stopping Imatinib Safe for CML Pts With Deep Response
March 5, 2016,   Clinical Oncology News

CML-CP Patients With Mild to Moderate Renal, Liver Dysfunction Can Safely Receive Frontline TKIs
March 4, 2016,  Cancer Therapy Advisor

As “Me-Too” Options Expand, Cost, Side Effects Become Considerations, McCullough Explains
March 4, 2016,   AJMC.com

Couple looks to wedding after cancer diagnosis
February 29, 2016, Northern Star

Family, friends run for local man living with leukemia
February 28, 2016,  Oakland Press

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
February 28, 2016,  Dove Medical Press
 
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016, Leukemia

At AGBT, Researchers Describe Using Long Reads for Clinical Applications
February 26,  2016, GenomeWeb

Leading Researchers, Clinicians, Policy and Drug Development Experts, and Cancer Survivors Convene to Discuss Latest Advances and Challenges in Treating Blood Cancers
February 25,  2016,  PRNewswire

Isabel Cunningham Holds CML Question-and-Answer Session With Jane Apperley, MD
February 24, 2016, Cancer Therapy Advisor

Switching to Nilotinib May Reduce Imatinib-related Adverse Events in CML
February 23, 2016 ,Cancer Therapy Advisor
 
Antibody-TKI Combination Impairs Leukemia Stem Cells
February 23, 2016, LWW Journals

CLINE: Mill Creek student has built a solid Foundation
February 23, 2016, Gwinnett Daily post 
 
He overcame cancer, now fights for others
February 23, 2016,  Asbury Park Press

EnvoyHealth Selected by Sun Pharma to Support Imatinib Mesylate Patient Program
February 22, 2016, PrNewswire

Citing higher cancer risk, lawmakers consider workers' comp provision for firefighters
February 22, 2016, Meriden Record-Journal

Chronic Myeloid Leukemia Treatment Discontinuation    VIDEO
February 22, 2016,  Oncology nursing News

Mtss1 'tumour suppressor' for CMLMtss1 'tumour suppressor' for CML
February 17, 2016,  News Medical

BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia
February 16, 2016, Cancer Therapy Advisor

Excitement at new cancer treatment
February 16,2016, BBC.com

Birmingham to lead the way with breakthrough cancer treatment
February 16, 2016,  cureleukemia

"Revolutionary" Cancer Therapy Yields Extraordinary Results In Human Trials
February 16, 2016, IFLScience

Cell marker found for leukemia-initiating capacity in chronic myelogenous leukemia
February 15, 2016, UAB News

The Write Stuff | Learning Kintsugi
February 11, 2016, The Courier-Journal

At 5 Years, Nilotinib Offers Benefit Over Imatinib in CML
February 10, 2016, Cancer Network
 
In CML: Radotinib as Frontline Therapy; Ponatinib Promising for T315I Patients
February 10, 2016, Oncology Times

Importance of Monitoring Patients with Chronic Myeloid Leukemia        VIDEO
February 10, 2016, OncLive
 
Relief in sight for cancer patients
February 9, 2016, Jackson Sun

Depression: cancer's invisible side effect
February 8, 2016, HealthCanal.com

New personalized DNA-based digital assay has potential to dramatically impact CML management
February 8, 2016,  News-Medical.net

Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
February 6, 2016, Expert Review of Hematology

​Edible Pedal founder battles Leukemia with support from restaurant community
February 5, 2016,  Sacramento Bee

New assay detects persistent disease in leukemia patients thought to be in remission
February 5, 2016 , EurekAlert

Dr. Nguyen on ABL001 in Patients With CML               VIDEO   
February  5,  2016, OncLiveTV

Dasatinib, Nilotinib, Ponatinib Increase Vascular Occlusive Events
February 4, 2016, Oncology Nurse Advisor  

Measuring Response in Chronic Myeloid Leukemia Treatment
February 4, 2016, OncLive

Woman honoured for her work with leukaemia patients
February 2, 2016, itv

CML: Study Evaluates Long-term Outcomes After Imatinib Discontinuation
February 1, 2016, Cancer Therapy Advisor

Upfront Treatment of Chronic Myeloid Leukemia CML                VIDEO
February 1, 2016, OncLive

Modest Price Cut Expected For Generic Version Of Cancer Pill Gleevec 
February 1, 2016,  NPR

Sun Pharma launches Gleevec's generic in US
February 1, 2016, Business Standard

What Is the Optimal Dose and Schedule for Dasatinib in Chronic Myeloid Leukemia: Two Case Reports and Review of the Literature
February 2016, PublMed

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring
February 2016, PublMed

MTSS1 Protein May Act As Tumor Suppressor, Downregulated in CML
January 29, 2016, CancerNetwork

Hematopoietic Transplant Remains Valid Option for CML in Era of TKIs
January 29, 2016, Cancer Therapy Advisor

Elevated Imatinib Dose, Second-generation TKIs Have Superior Responses in CML
January 28, 2015, Cancer Therapy Advisor

Select patients with CML may safely discontinue dasatinib
January 28, 2016, Healio
 
Researcher Identifies Role of SETBP1 in Myeloid Leukemia Development
January 27, 2016, India West
  
Insurance Status Determines OS in Patients With CML
January 27, 2016, AJMC.com Managed Markets Network

Novel oral transforming growth factor-β signaling inhibitor EW-7197 eradicates CML-initiating cells
January 26, 2016, Cancer Science

Clinical Goals of Treating CML        VIDEO
January 24, 2016, OncLive

How A Canadian Researcher Is Advancing Breakthrough Therapies
January 22, 2016, Personal Health News

Positive bosutinib response for elderly blast phase CML patient
January 22, 2016,   News-Medical.net

'Multiple Low-level BCR-ABL1 Mutations Not Associated With Poor Response to Ponatinib in CML
January 19, 2016, Cancer Therapy Advisor

CML: First-line Therapy with Dasatinib + Pegylated Interferon Induces Deep Molecular Responses
January 15, 2016, LWW Journals
 
Radotinib Effective, Safe for Newly Diagnosed CML-CP
January 14, 2016, Cancer Therapy Advisor

Novel Therapies Likely to Change Role of Stem Cell Transplants in Blood Cancers
January 14, 2016, OncLive

Early Personalization of Imatinib Dose May Improve Outcomes for CP-CML
January 14, 2016, Cancer Therapy Advisor

Mutation Analysis in Chronic Myeloid Leukemia    VIDEO
January 14, 2016, OncLive

Insulin Sensitivity Improved With PPARy Antagonist Imatinib
January 13, 2016, MPR

Pioglitazone, Other TZDs May Add Benefit to TKI Therapy in CML
January 11, 2015, CancerNetwork

Ponatinib vs Allogeneic SCT Promising for T315I Mutation-positive CP-CML
January 11, 2016, Cancertherapyadvisor

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
January 8, 2016, Blood Cancer journal
 
BCR-ABL Transcript Type Predicts TKI Response in CML
January 6, 2016, Cancer Therapy Advisor

<

                See Archives ( 2019-2018)       
                See Archives ( 2015-2014)
                See Archives ( 2013-2012)
                See Archives before 2012